Advances in Liquid Biopsy for the Diagnosis of Breast Cancer
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 1068
Special Issue Editor
Interests: hereditary breast cancer; male breast cancer; lymph node metastasis; tumor microenvironment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Liquid biopsy refers to the process of obtaining tumor-derived material, such as tumor DNA, RNA, or extracellular vesicles, from body fluids such as blood, urine, and saliva. The relatively non-invasive nature of the material obtained using methods such as blood or urine collection makes it an attractive method of investigation compared to traditional tumor biopsy. It also has the advantage of overcoming the problem of tumor heterogeneity by sampling the entire genomic environment of the tumor present in the patient's body, and it provides the possibility of repeating the test over time, allowing for longitudinal monitoring of the tumor and anti-inflammatory drugs.
It may also have potential for the early detection of cancer, predicting prognosis, and predicting response to treatment. In recent years, the development of highly sensitive assays capable of detecting tumor-derived material in body fluids, often in minutes, has made liquid biopsy a viable alternative to conventional tumor biopsy.
Dr. Chihwan David Cha
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- diagnosis
- metastasis
- ctDNA
- liquid biopsy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
